Chromatin remodeling: Recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase

FASEB Journal

Volumn 24, Issue 2, 2010, Pages 579-586

  Ge, Zheng ^a   Li, Wenjuan ^a,b   Wang, Na ^a   Liu, Cheng ^a   Zhu, Qingjun ^a,c   Björkholm, Magnus ^a   Gruber, Astrid ^a   Xu, Dawei ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Differentiation; E box; HDM; hTERT; Immortalization; MYC MAX MAD

Indexed keywords

ACTIN; BETA 2 MICROGLOBULIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; HISTONE DEMETHYLASE RBP2; MAX PROTEIN; MESSENGER RNA; MYC PROTEIN; PROTEIN MAD1; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CELL STRAIN HL 60; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DEMETHYLATION; DISSOCIATION; FIBROBLAST; GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HTERT GENE; HUMAN; HUMAN CELL; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN-REGULATION; E-BOX ELEMENTS; GENE EXPRESSION; HISTONE DEMETHYLASES; HL-60 CELLS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA-BINDING PROTEIN 2; TELOMERASE;

EID: 76149093576     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-140087     Document Type: Article

References (54)

1. Cole, M. D., and Henriksson, M. (2006) 25 years of the c-Myc oncogene. Semin. Cancer Biol. 16, 241
2. Nikiforov, M. A., Chandriani, S., Park, J., Kotenko, I., Matheos, D., Johnsson, A., McMahon, S. B., and Cole, M. D. (2002) TRRAPdependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22, 5054-5063
3. McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., and Cole, M. D. (1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374
4. Ayer, D. E., Lawrence, Q. A., and Eisenman, R. N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776
5. Shi, Y., and Whetstine, J. R. (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25, 1-14
6. Ruthenburg, A. J., Allis, C. D., and Wysocka, J. (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 25, 15-30
7. Secombe, J., and Eisenman, R. N. (2007) The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection. Cell Cycle 6, 1324-1328
8. Berger, S. L. (2007) The complex language of chromatin regulation during transcription. Nature 447, 407-412
9. Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A., and Kaelin, W. G. Jr. (2005) Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18, 623-635
10. Christensen, J., Agger, K., Cloos, P. A., Pasini, D., Rose, S., Sennels, L., Rappsilber, J., Hansen, K. H., Salcini, A. E., and Helin, K. (2007) RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128, 1063-1076
11. Klose, R. J., Yan, Q., Tothova, Z., Yamane, K., Erdjument-Bromage, H., Tempst, P., Gilliland, D. G., Zhang, Y., and Kaelin, W. G., Jr. (2007) The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128, 889-900
12. Secombe, J., Li, L., Carlos, L., and Eisenman, R. N. (2007) The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev. 21, 537-551
13. Shay, J. W., and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer. 33, 787-791
14. Blackburn, E. H., Greider, C. W., and Szostak, J. W. (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 12, 1133-1138
15. Blasco, M. A. (2005) Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6, 611-622
16. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H., Meyerson, M., and Weinberg, R. A. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164-1170
17. Zhang, X., Mar, V., Zhou, W., Harrington, L., and Robinson, M. O. (1999) Telomere shortening and apoptosis in telomeraseinhibited human tumor cells. Genes Dev. 13, 2388-2399
18. Cassar, L., Nicholls, C., Pinto, A. R., Li, H., and Liu, J. P. (2009) Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. FASEB J. 23, 1880-1892
19. Cong, Y. S., Wright, W. E., and Shay, J. W. (2002) Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66, 407-425
20. Lin, S. Y., and Elledge, S. J. (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889
21. Liu, J. P. (1999) Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13, 2091-2104
22. Horikawa, I., and Barrett, J. C. (2003) Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24, 1167-1176
23. Lai, S. R., Phipps, S. M., Liu, L., Andrews, L. G., and Tollefsbol, T. O. (2005) Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems. Front. Biosci. 10, 1779-1796
24. Wang, S., and Zhu, J. (2003) Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J. Biol. Chem. 278, 18842-18850
25. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A. R., and Henriksson, M. (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. U. S. A. 98, 3826-3831
26. Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Bjorkholm, M., Henriksson, M., Gruber, A., and Xu, D. (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274, 25-34
27. Cong, Y. S., and Bacchetti, S. (2000) Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J. Biol. Chem. 275, 35665-35668
28. Guilleret, I., and Benhattar, J. (2003) Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp. Cell. Res. 289, 326-334
29. Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., and Benhattar, J. (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int. J. Cancer 101, 335-341
30. Takakura, M., Kyo, S., Sowa, Y., Wang, Z., Yatabe, N., Maida, Y., Tanaka, M., and Inoue, M. (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 29, 3006-3011
31. Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V., and Benhattar, J. (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res. 35, 1245-1256
32. Wooten-Blanks, L. G., Song, P., Senkal, C. E., and Ogretmen, B. (2007) Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1. FASEB J. 21, 3386-3397
33. Atkinson, S. P., Hoare, S. F., Glasspool, R. M., and Keith, W. N. (2005) Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 65, 7585-7590
34. Liu, C., Fang, X., Ge, Z., Jalink, M., Kyo, S., Bjorkholm, M., Gruber, A., Sjoberg, J., and Xu, D. (2007) The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res. 67, 2626-2631
35. Kumakura, S., Tsutsui, T. W., Yagisawa, J., Barrett, J. C., and Tsutsui, T. (2005) Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res. 65, 2778-2786
36. Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., and Herman, J. G. (2007) hTERT is expressed in cancer cell lines despite promoterDNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 67, 194-201
37. Cerezo, A., Kalthoff, H., Schuermann, M., Schafer, B., and Boukamp, P. (2002) Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J. Cell. Sci. 115, 1305-1312
38. Gunes, C., Lichtsteiner, S., Vasserot, A. P., and Englert, C. (2000) Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60, 2116-2121
39. Xu, D., Dwyer, J., Li, H., Duan, W., and Liu, J. P. (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J. Biol. Chem. 283, 23567-23580
40. Ogretmen, B., Kraveka, J. M., Schady, D., Usta, J., Hannun, Y. A., and Obeid, L. M. (2001) Molecular mechanisms of ceramidemediated telomerase inhibition in the A549 human lung adenocarcinoma cell line. J. Biol. Chem. 276, 32506-32514
41. Schlosser, I., Holzel, M., Hoffmann, R., Burtscher, H., Kohlhuber, F., Schuhmacher, M., Chapman, R., Weidle, U. H., and Eick, D. (2005) Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 24, 520-524
42. Schuhmacher, M., Staege, M. S., Pajic, A., Polack, A., Weidle, U. H., Bornkamm, G. W., Eick, D., and Kohlhuber, F. (1999) Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255-1258
43. Xu, D., Gruber, A., Peterson, C., and Pisa, P. (1998) Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br. J. Haematol. 102, 1367-1375
44. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59, 551-557
45. Ge, Z., Liu, C., Bjorkholm, M., Gruber, A., and Xu, D. (2006) Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation. Mol. Cell. Biol. 26, 230-237
46. Xu, D., Gruber, A., Peterson, C., and Pisa, P. (1996) Supression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 10, 1354-1357
47. Xu, D., Gruber, A., Bjorkholm, M., Peterson, C., and Pisa, P. (1999) Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br. J. Cancer 80, 1156-1161
48. Holt, S. E., Wright, W. E., and Shay, J. W. (1996) Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16, 2932-2939
49. Sharma, H. W., Sokoloski, J. A., Perez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N. T., and Narayanan, R. (1995) Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. U. S. A. 92, 12343-12346
50. Jalink, M., Ge, Z., Liu, C., Bjorkholm, M., Gruber, A., and Xu, D. (2007) Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA. Biochem. Biophys. Res. Commun. 353, 999-1003
51. Knoepfler, P. S., Zhang, X. Y., Cheng, P. F., Gafken, P. R., McMahon, S. B., and Eisenman, R. N. (2006) Myc influences global chromatin structure. EMBO J. 25, 2723-2734
52. Wu, C. H., van Riggelen, J., Yetil, A., Fan, A. C., Bachireddy, P., and Felsher, D. W. (2007) Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc. Natl. Acad. Sci. U. S. A. 104, 13028-13033
53. Wissmann, M., Yin, N., Muller, J. M., Greschik, H., Fodor, B. D., Jenuwein, T., Vogler, C., Schneider, R., Gunther, T., Buettner, R., Metzger, E., and Schule, R. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptordependent gene expression. Nat. Cell. Biol. 9, 347-353
54. Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall' Olio, V., Zardo, G., Nervi, C., Bernard, L., and Amati, B. (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell. Biol. 8, 764 - 770